FEV1/FVC Ratio Calculator (Tiffeneau Index)

For most adults under 65, the widely used threshold is 0.70 (70%). A ratio at or above 0.70 is generally considered normal. For adults 65 and older, 0.65 is sometimes used because the ratio naturally declines with age: using the fixed 0.70 cut-off can label healthy older adults as obstructed. A more precise approach is to compare your ratio to the Lower Limit of Normal (LLN) derived from a reference population, which accounts for age, sex, height, and ethnicity simultaneously.

A ratio below the lower limit of normal indicates an obstructive ventilatory defect. This means air leaves the lungs more slowly than expected, consistent with narrowing of the airways. Common causes include COPD (chronic bronchitis and emphysema), asthma, bronchiectasis, and cystic fibrosis. The ratio alone does not tell you which condition is present; your doctor will combine it with your symptoms, history, imaging, and other tests to reach a diagnosis.

FEV1/FVC tells you the speed of exhalation relative to total exhaled volume: it identifies the presence of obstruction. FEV1 percent predicted tells you how much airflow limitation you have compared with what is normal for someone your age, sex, height, and ethnicity: once obstruction is confirmed, it grades the severity. A GOLD 1 patient might have an FEV1/FVC of 0.65 and an FEV1 of 85% predicted; a GOLD 4 patient could have the same low ratio but an FEV1 below 30% predicted.

Spirometry is an important tool but cannot diagnose asthma on its own. Obstruction that reverses substantially (FEV1 improves by at least 200 mL and 12% after a bronchodilator) strongly supports asthma. However, some asthma patients have normal spirometry between episodes, and some COPD patients show partial reversibility. A complete diagnosis requires clinical history, symptom patterns, bronchial challenge tests, peak-flow diaries, and sometimes allergy testing.

Population reference studies consistently show that, at any given age and height, Black individuals have lower average FEV1 and FVC than White individuals, and Hispanic and Asian individuals fall between. The differences likely reflect a combination of body-proportionality differences (trunk-to-leg-length ratio affects thoracic volume), socioeconomic, environmental, and historical factors. Current reference equations apply multiplicative correction factors (0.87 for Black, 0.93 for Hispanic and Asian) to the White baseline values. This practice is controversial because it may obscure real disease in some individuals: emerging guidelines recommend Z-score-based interpretation with race-neutral or GLI-global equations.

GOLD (Global Initiative for Chronic Obstructive Lung Disease) staging applies specifically to patients who have confirmed airflow obstruction, meaning a post-bronchodilator FEV1/FVC ratio below 0.70. The four grades (1 to 4) classify obstruction severity based on FEV1 as a percent of predicted: GOLD 1 (Mild) is 80% or above, GOLD 2 (Moderate) is 50-79%, GOLD 3 (Severe) is 30-49%, and GOLD 4 (Very Severe) is below 30%. GOLD staging is one part of the overall COPD assessment, which also considers symptoms and exacerbation history.

Predicted values are population averages and confidence intervals, not exact targets for any individual. Up to 5% of healthy people will fall below the 80% threshold purely by statistical distribution, and individual variation in body proportions, fitness, and genetics means that a single reading slightly below 80% may be normal for one person. This is why the LLN (Lower Limit of Normal at the 5th percentile) is preferred over the fixed 80% cutoff: it accounts for the natural spread in the reference population. Always interpret results with a clinician who knows your full medical history.